from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3856c/-

LFCtreatmentdescriptionclass of inhibitor

-1.790

Amikacinug/mL Amikacintranslation

-1.088

Cap5-10ug/mL Capreomycintranslation

-1.005

Rox10-50 ug/mL Roxithromycintranslation

0.177

SM2-5 ug/mL Streptomycintranslation

-0.878

Tet5-10 ug/mL Tetracyclinetranslation

-0.784

Rif0.2-5ug/mL Rifampicintranscription

-0.041

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.019

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.451

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.166

CPZ10-50 ug/mL Chlorpromazinerespiration

0.916

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.236

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.855

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.544

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.083

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.299

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.240

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.519

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.053

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.025

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.357

KCN5-20 ug/mL Potassium cyaniderespiration

-0.013

NaN30.2-2 mM Sodium aziderespiration

-0.468

Nigericin50 uM Nigericinrespiration

0.193

TRC10-150 ug/mL Triclosanrespiration

0.086

TRZ10-25 ug/mL Thioridazinerespiration

0.237

Valinomycin0.5-10 uM Valinomycinrespiration

1.278

ZnSO42 mM ZnSO4respiration

0.126

menadione6-10 ug/mL Menadionerespiration

-0.136

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.485

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.456

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.247

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.267

NRP_1Non-replicating persistence stage 1dosRassociated

-0.829

Amp0.2mg/mL AmpicillincellWall

-0.051

Cephalexin20-100 ug/mL CephalexincellWall

-0.377

Cerulenin0.32-5 ug/mL CerulenincellWall

0.261

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.471

EMB10-20 ug/mL EthambutolcellWall

0.078

Eta12-40 ug/mL EthionamidecellWall

0.059

INH0.2-0.4 ug/mL IsoniazidcellWall

0.050

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.739

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.447

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.575

BZA0.12 mg/mL BenzamidearomaticAmides

0.796

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.300

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.366

H2O24 mM hydrogen peroxideDNAdamaging

-0.771

Levo10 ug/mL LevofloxacinDNAdamaging

-0.217

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.463

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.955

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.042

UVUV-irradiationDNAdamaging

-0.187

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.508

Antimycin12.5-50 ug/mL Antimycin A?

-0.194

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.431

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.444

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.643

PA8240.2-2 ug/mL PA-824?

1.803

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.295

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.074

Verapamil50 uM Verapamil?

-0.587

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.267

methoxatin10-20 ug/mL Methoxatin?